This multicentre study identifies the most important predictors of early new-onset AKI and the need for RRT at ICU admission using XAI, highlighting both emerging biomarkers, such as endostatin and NGAL, and established biomarkers, including lactate and albumin. The gene discussed is COL18A1; the disease is acute kidney injury.